All the updated news related to donanemab

All the news related to donanemab updated in real time

Found 13

fordonanemab

Order by:

Alzheimer’s drug rejected for widespread use by NHS spending watchdog

A new Alzheimer’s drug has been rejected for widespread use in the health service in England after the health spending watchdog said it “does not currently demonstrate value for the NHS”. The news comes as the UK’s medicines regulator said donanemab ...

23 Oct 2024 at 10:48

Decision expected on new Alzheimer’s treatment

Alzheimer’s patients are set to find out whether a new drug could become available in the UK as health regulators are poised to announce their decision on donanemab. The treatment – one of two new drugs to target a cause of the disease – has been ...

22 Oct 2024 at 22:25

‘Turning point in the fight against Alzheimer’s’ as drug found to slow disease

A new drug has been hailed as a “turning point in the fight against Alzheimer’s” after it was found to slow the progression of the disease. Donanemab was found to slow “clinical decline” by up to 35%, meaning that people with the disease could ...

17 Jul 2023 at 15:27

World

FDA approves second Alzheimer’s drug that can modestly slow disease

US officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration (FDA) approved Eli ...

03 Jul 2024 at 11:28

All you need to know about the Alzheimer’s drug which was rejected for NHS use

Lecanemab – a drug shown to slow the progression of Alzheimer’s disease – has been approved for use, but will not be available on the NHS. The National Institute for Health and Care Excellence (Nice) said the benefits of lecanemab are too ...

22 Aug 2024 at 14:42

Donanemab – what we know about the latest Alzheimer’s drug

Donanemab can slow the progression of Alzheimer’s disease. But what is the drug and how does it work? Here your questions on the latest development in Alzheimer’s research are answered. – What kind of treatment is Donanemab? Donanemab is ...

23 Oct 2024 at 10:00

Alzheimer’s drugs ‘will not address dementia risk at scale’, researchers claim

New drugs being developed to tackle Alzheimer’s disease “will not address dementia risk at scale”, researchers have warned. Academics said there is “a lot of hyperbole” around medications such as lecanemab and donanemab which are said ...

06 Aug 2024 at 12:00

Clear need to improve NHS screening for new Alzheimer’s drugs – study

There is a “clear and urgent” need to improve NHS screening to work out who may benefit from new Alzheimer’s drugs, according to a study. Experts found that just 14% of people screened in specialist clinics may end up benefiting from ...

11 Jun 2024 at 23:30

NHS England sets up team to plan rollout of promising new drugs

NHS England has set up a team that will plan how to roll out promising new drugs even as they wait to be approved by regulators, the chief executive of the health service has said. It comes after new drug donanemab was found to slow ...

02 Jul 2023 at 13:47

New drug found to slow Alzheimer’s hailed as turning point

17 Jul 2023 at 18:41

How do the new antibody drugs for Alzheimer’s disease work?

Two new drugs for Alzheimer’s have been rejected for use on the NHS. They slow progression of the disease, but they can have serious side-effects. – What are the medicines? Donanemab and lecanemab are targeted antibody drugs ...

19 Jun 2025 at 00:01

Why is this Alzheimer’s breakthrough so important?

Results from a clinical trial have been hailed as a “turning point in the fight against Alzheimer’s disease”. But what is the new drug and how does it work? Here are your questions answered. – What is the drug and how does ...

17 Jul 2023 at 17:16

Years
2026

Related keywords
alzheimer's
alzheimer's disease
donanemab
eli lilly
kisunla
medicines and healthcare products regulatory agency
national institute for health and care excellence
nice

Iconic Media is Ireland's largest independently owned regional newspaper and media group, with an unrivalled audience in print, online and mobile. We have 19 regional newspapers and 21 digital sites.

Iconic Digital Titles

Iconic Print Titles

Letterkenny Live

This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, Lo-call 1800 208 080 or email: info@presscouncil.ie.